Engeletin inhibits Lipopolysaccharide/d-galactosamine-induced liver injury in mice through activating PPAR-γ
2019 · Journal of Pharmacological Sciences · 20 citations
https://doi.org/10.1016/j.jphs.2019.06.011
Y
Yamin Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
500
Citations
14
h-index
18
i10-index
Yamin Zhang is an academic researcher from Tianjin First Center Hospital. The author has contributed to research in topics: Organ Transplantation Techniques and Outcomes & Transplantation: Methods and Outcomes & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 14, co-authored 62 publications.
ORCID: 0000-0001-7886-2901Papers by this author
worksHepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma
2023 · Clinical Epigenetics · 13 citations
https://doi.org/10.1186/s13148-023-01508-7
Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma
2023 · BMC Medical Imaging · 9 citations
https://doi.org/10.1186/s12880-023-01069-4
Integrative analysis based on ATAC-seq and RNA-seq reveals a novel oncogene PRPF3 in hepatocellular carcinoma
2024 · Clinical Epigenetics · 6 citations
https://doi.org/10.1186/s13148-024-01769-w
Upregulated SSB Is Involved in Hepatocellular Carcinoma Progression and Metastasis through the Epithelial-Mesenchymal Transition, Antiapoptosis, and Altered ROS Level Pathway
2023 · Oxidative Medicine and Cellular Longevity · 3 citations
https://doi.org/10.1155/2023/5207431
A novel predictive model of microvascular invasion in hepatocellular carcinoma based on differential protein expression
2023 · BMC Gastroenterology · 3 citations
https://doi.org/10.1186/s12876-023-02729-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat